Drafting And Prosecuting Applications For Polymorphs Of Drug Compounds At The EPO (Video)

J A Kemp is a leading firm of European Patent and Trade Mark Attorneys. We combine independent thinking with collective excellence in all that we do. The technical and legal knowledge that we apply to the protection of our clients’ patents is outstanding in its breadth and depth. With around 100 science and technology graduates in the firm, including 50 PhDs, no area of science or technology is outside our scope. Our Patent Attorneys have collective in-depth expertise in patent law and procedure in every country of the world. The team of professionals who advise our clients on trade mark and design matters have backgrounds in major international law firms and hold qualifications as Chartered UK Trade Mark Attorneys, Solicitors and European Trade Mark Professional Representatives. Dedicated to this specialist area of intellectual property protection, the team has the expertise and resources to protect trade marks and designs in any market worldwide.

Explore Firm Details

This webinar, hosted by Guy Brain and Chris Milton, explores key considerations for patents on pharmaceutical polymorphs at the European Patent Office. Topics include effective drafting strategies, establishing novelty and inventive steps, addressing common challenges, and insights from recent case law and trends.

United Kingdom Intellectual Property

Article Insights

This article from J A Kemp LLP is most popular:

in India
with readers working within the Retail & Leisure industries

J A Kemp LLP are most popular:

within Energy and Natural Resources topic(s)
with readers working within the Environment & Waste Management and Transport industries

Broadcast date: 31 October 2024 — Speakers: Guy Brain, Chris Milton

Patents directed to polymorphs of pharmaceutical compounds can be of significant commercial importance. However, care needs to be taken both during drafting and prosecution to increase the chance of success at the European Patent Office. This webinar will discuss some of the issues faced for patent applications for polymorphs and how those issues can be addressed at the EPO, as well as looking at some recent case law.

Topics will include:

How to draft claims directed to polymorphs
Other drafting tips for polymorph applications
Establishing novelty and inventive step for polymorphs
Other issues for polymorph applications
Recent decisions and trends in the polymorph case law at the EPO

self

J A Kemp LLP acts for clients in the USA, Europe and globally, advising on UK and European patent practice and representing them before the European Patent Office, UKIPO and Unified Patent Court. We have in-depth expertise in a wide range of technologies, including Biotech and Life Sciences, Pharmaceuticals, Software and IT, Chemistry, Electronics and Engineering and many others. See our website to find out more.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Drafting And Prosecuting Applications For Polymorphs Of Drug Compounds At The EPO (Video)

Contributor

Intellectual Property

Contributor

United Kingdom